(Q21202912)

English

Acromegaly

scientific article 2008

In more languages

Statements

scholarly article

0 references

1 reference

20 November 2019

Acromegaly (English)

0 references

1 reference

20 November 2019

human growth hormone

1 reference

20 November 2019

Sylvie Salenave

2

author given names

Sylvie

author last names

Salenave

object named as

Sylvie Salenave

1 reference

Dimensions Publication ID

18 August 2022

Philippe Chanson

1

author given names

Philippe

author last names

Chanson

object named as

Philippe Chanson

1 reference

Dimensions Publication ID

18 August 2022

language of work or name

0 references

publication date

25 June 2008

6 references

14 February 2019

13 March 2019

24 March 2019

25 April 2019

17 November 2019

20 November 2019

Orphanet Journal of Rare Diseases

6 references

14 February 2019

13 March 2019

24 March 2019

25 April 2019

17 November 2019

20 November 2019

3

0 references

1

0 references

17

0 references

copyright license

Creative Commons Attribution 2.0 Generic

6 references

Europe PubMed Central

14 February 2019

Europe PubMed Central

13 March 2019

Europe PubMed Central

24 March 2019

Europe PubMed Central

25 April 2019

Europe PubMed Central

17 November 2019

Europe PubMed Central

20 November 2019

copyright status

0 references

on focus list of Wikimedia project

0 references

Treatment of acromegaly with the GH receptor antagonist pegvisomant in clinical practice: safety and efficacy evaluation from the German Pegvisomant Observational Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

19 March 2017

Epithelial sodium channel is a key mediator of growth hormone-induced sodium retention in acromegaly.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

12 September 2017

McCune-Albright syndrome in adulthood

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

12 September 2017

Pituitary tumor-transforming gene: physiology and implications for tumorigenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

12 September 2017

Endoscopic endonasal transsphenoidal approach: an additional reason in support of surgery in the management of pituitary lesions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

12 September 2017

Medical progress: Acromegaly

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

12 September 2017

High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

12 September 2017

Carney complex (CNC).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

12 September 2017

Gross total resection or debulking of pituitary adenomas improves hormonal control of acromegaly by somatostatin analogs.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

12 September 2017

Endoscopic endonasal transsphenoidal surgery

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

12 September 2017

Molecular targets in pituitary tumours

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

12 September 2017

Systemic complications of acromegaly: epidemiology, pathogenesis, and management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

12 September 2017

Acromegaly and colorectal cancer: a comprehensive review of epidemiology, biological mechanisms, and clinical implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

12 September 2017

Mechanisms for pituitary tumorigenesis: the plastic pituitary

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

12 September 2017

Cardiovascular function in acromegaly

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

12 September 2017

Gamma knife radiosurgery in the management of patients with acromegaly: a review.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

12 September 2017

The pathogenesis of pituitary tumours

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

12 September 2017

Growth hormone receptor antagonists: discovery, development, and use in patients with acromegaly.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

12 September 2017

Guidelines for acromegaly management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

12 September 2017

Somatostatin analogs in acromegaly

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

12 September 2017

Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

12 September 2017

Guidelines for diagnosis and therapy of MEN type 1 and type 2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

12 September 2017

Clinical perspective: acromegaly and cancer: a problem

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

12 September 2017

Acromegaly and cancer: not a problem?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

12 September 2017

Relationship between blood pressure and glucose tolerance in acromegaly.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

12 September 2017

Epidemiology of acromegaly

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

12 September 2017

Vascular reactivity in acromegalic patients: preliminary evidence for regional endothelial dysfunction and increased sympathetic vasoconstriction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

12 September 2017

Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

12 September 2017

Criteria for cure of acromegaly: a consensus statement

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

12 September 2017

Growth hormone heterogeneity in human pituitary and plasma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

12 September 2017

Medical therapy for acromegaly.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

12 September 2017

Pituitary carcinoma: a clinicopathologic study of 15 cases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

12 September 2017

The prevalence of colonic polyps in acromegaly: a colonoscopic and pathological study in 103 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

12 September 2017

Somatotroph hyperplasia. Successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

12 September 2017

Silent somatotroph adenomas of the human pituitary. A morphologic study of three cases including immunocytochemistry, electron microscopy, in vitro examination, and in situ hybridization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

12 September 2017

Surgical management of acromegaly

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

12 September 2017

Rheumatologic and skeletal changes in acromegaly

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

12 September 2017

Clinical manifestations of acromegaly.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

12 September 2017

Pituitary irradiation is ineffective in normalizing plasma insulin-like growth factor I in patients with acromegaly

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

27 September 2017

Clinical pharmacokinetics of octreotide. Therapeutic applications in patients with pituitary tumours.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

27 September 2017

Thyrotropin-secreting pituitary tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

27 September 2017

Octreotide long-acting release (LAR). A review of its pharmacological properties and therapeutic use in the management of acromegaly

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

27 September 2017

The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical 'cure'.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

30 May 2018

Gamma-knife radiosurgery in acromegaly: a 4-year follow-up study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

30 May 2018

Primary medical therapy for acromegaly: an open, prospective, multicenter study of the effects of subcutaneous and intramuscular slow-release octreotide on growth hormone, insulin-like growth factor-I, and tumor size

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

30 May 2018

Acromegaly due to secretion of growth hormone by an ectopic pancreatic islet-cell tumor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

30 May 2018

Glycoprotein hormone alpha-subunit response to growth hormone (GH)-releasing hormone in patients with active acromegaly. Evidence for alpha-subunit and GH coexistence in the same tumoral cell

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

30 May 2018

Cardiovascular effects of the somatostatin analog octreotide in acromegaly

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

30 May 2018

Clonal origin of pituitary adenomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

30 May 2018

High prevalence of biochemical acromegaly in primary care patients with elevated IGF-1 levels

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

29 November 2018

Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

29 November 2018

Pituitary adenoma predisposition caused by germline mutations in the AIP gene.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

29 November 2018

A nationwide survey of mortality in acromegaly

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

29 November 2018

Decreased quality of life in patients with acromegaly despite long-term cure of growth hormone excess

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

29 November 2018

Effects of octreotide on sleep apnoea and tongue volume (magnetic resonance imaging) in patients with acromegaly

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

29 November 2018

Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-I concentrations, predict excess mortality in patients with acromegaly

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

29 November 2018

Diagnosis and treatment of acromegaly complications.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

29 November 2018

The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

29 November 2018

Acromegaly with apparently normal GH secretion: implications for diagnosis and follow-up

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

29 November 2018

Efficacy of the new long-acting formulation of lanreotide (lanreotide Autogel) in the management of acromegaly

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

29 November 2018

Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

29 November 2018

Effect of Sandostatin LAR on sleep apnoea in acromegaly: correlation with computerized tomographic cephalometry and hormonal activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

29 November 2018

Long-term effects of depot long-acting somatostatin analog octreotide on hormone levels and tumor mass in acromegaly

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

29 November 2018

Acromegaly Caused by Secretion of Growth Hormone by a Non-Hodgkin's Lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

29 November 2018

Systemic hypertension and impaired glucose tolerance are independently correlated to the severity of the acromegalic cardiomyopathy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

29 November 2018

Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

29 November 2018

Octreotide as primary therapy for acromegaly.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

29 November 2018

Reversibility of joint thickening in acromegalic patients: an ultrasonography study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

29 November 2018

Cabergoline in the treatment of acromegaly: a study in 64 patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2459162

29 November 2018

Germline inactivating mutations of the aryl hydrocarbon receptor-interacting protein gene in a large cohort of sporadic acromegaly: mutations are found in a subset of young patients with macroadenomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/18578866

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The pathology of median neuropathy in acromegaly

1 reference

https://pubmed.ncbi.nlm.nih.gov/18578866

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hormonal and metabolic effects of radiotherapy in acromegaly: long-term results in 128 patients followed in a single center

1 reference

https://pubmed.ncbi.nlm.nih.gov/18578866

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term outcome of patients with acromegaly and congestive heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/18578866

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of octreotide acetate LAR and lanreotide SR in patients with acromegaly

1 reference

https://pubmed.ncbi.nlm.nih.gov/18578866

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of octreotide pretreatment on surgical outcome in acromegaly

1 reference

https://pubmed.ncbi.nlm.nih.gov/18578866

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The incidence of cerebrovascular accidents in patients with pituitary adenoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18578866

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Control of tumor size and disease activity during cotreatment with octreotide and the growth hormone receptor antagonist pegvisomant in an acromegalic patient

1 reference

https://pubmed.ncbi.nlm.nih.gov/18578866

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term follow-up results of postoperative radiotherapy in 36 patients with acromegaly

1 reference

https://pubmed.ncbi.nlm.nih.gov/18578866

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Editorial: acromegaly--consensus, what consensus?

1 reference

https://pubmed.ncbi.nlm.nih.gov/18578866

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alterations in body composition in acromegaly

1 reference

https://pubmed.ncbi.nlm.nih.gov/18578866

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Skeletal involvement in female acromegalic subjects: the effects of growth hormone excess in amenorrheal and menstruating patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/18578866

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Factors influencing mortality in acromegaly

1 reference

https://pubmed.ncbi.nlm.nih.gov/18578866

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Osteoarticular disorders of endocrine origin

1 reference

https://pubmed.ncbi.nlm.nih.gov/18578866

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Consensus statement on the standardisation of GH assays

1 reference

https://pubmed.ncbi.nlm.nih.gov/18578866

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acromegaly. Clinical and biochemical features in 500 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/18578866

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ten-year follow-up results of transsphenoidal microsurgery in acromegaly

1 reference

https://pubmed.ncbi.nlm.nih.gov/18578866

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased prevalence of regurgitant valvular heart disease in acromegaly

1 reference

https://pubmed.ncbi.nlm.nih.gov/18578866

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum growth hormone measurements in clinical practice: An audit of performance from the UK National External Quality Assessment scheme

1 reference

https://pubmed.ncbi.nlm.nih.gov/18578866

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mutations in theAryl Hydrocarbon Receptor Interacting ProteinGene Are Not Highly Prevalent among Subjects with Sporadic Pituitary Adenomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/18578866

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outcome of gamma knife radiosurgery in 82 patients with acromegaly: correlation with initial hypersecretion

1 reference

https://pubmed.ncbi.nlm.nih.gov/18578866

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High Prevalence of Cardiac Valve Disease in Acromegaly: An Observational, Analytical, Case-Control Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18578866

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Less is more risky? Growth hormone and insulin-like growth factor 1 levels and cardiovascular risk

1 reference

https://pubmed.ncbi.nlm.nih.gov/18578866

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/18578866

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long term effect of incremental doses of the somatostatin analog SMS 201-995 in 58 acromegalic patients. French SMS 201-995 approximately equal to Acromegaly Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/18578866

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Growth hormone and the heart

1 reference

https://pubmed.ncbi.nlm.nih.gov/18578866

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/18578866

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of Acromegaly with the Growth Hormone–Receptor Antagonist Pegvisomant

1 reference

https://api.crossref.org/works/10.1186%2F1750-1172-3-17

7 January 2021

based on heuristic

inferred from DOI database lookup

The prevalence of colonic polyps in acromegaly: a colonoscopic and pathological study in 103 patients

1 reference

https://api.crossref.org/works/10.1186%2F1750-1172-3-17

7 January 2021

based on heuristic

inferred from DOI database lookup

Acromegaly--Consensus, What Consensus?

1 reference

https://api.crossref.org/works/10.1186%2F1750-1172-3-17

7 January 2021

based on heuristic

inferred from DOI database lookup

Ketorolac. A reappraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic use in pain management

1 reference

https://api.crossref.org/works/10.1186%2F1750-1172-3-17

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1186/1750-1172-3-17

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Dimensions Publication ID

0 references

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PMC publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PubMed publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q21202912&oldid=2176678895"